TABLE 2.
Sample type | n | Sensitivity (%) | 95% CI |
---|---|---|---|
CT values <15 | |||
Oral | 3 | 100.00 | 29.24–100.00 |
AN | 3 | 100.00 | 29.24–100.00 |
NP | 3 | 100.00 | 29.24–100.00 |
CT values 15 to <20 | |||
Oral | 6 | 33.33 | 4.33–77.72 |
AN | 6 | 100.00 | 54.07–100.00 |
NP | 6 | 100.00 | 54.07–100.00 |
CT values 20 to <25 | |||
Oral | 16 | 18.75 | 4.05–45.65 |
AN | 16 | 93.75 | 69.77–99.84 |
NP | 16 | 93.75 | 69.77–99.84 |
CT values 25 to <30 | |||
Oral | 12 | 0.00 | 0.00–26.46 |
AN | 14 | 35.71 | 12.76–64.86 |
NP | 14 | 42.86 | 17.66–71.14 |
CT values 30 to <35 | |||
Oral | 7 | 0.00 | 0.00–40.96 |
AN | 7 | 0.00 | 0.00–40.96 |
NP | 6 | 50.00 | 11.81–88.19 |
All CT values | |||
Oral | 44 | 18.18 | 8.19–32.71 |
AN | 46 | 63.04 | 47.55–76.79 |
NP | 45 | 73.33 | 58.06–85.40 |
AN, anterior nasal; NP, nasopharyngeal; CI, confidence interval; CT, cycle threshold.